Evaxion Biotech AS (EVAX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $25.27M
Last updated: Nov 17, 2026 at 11:01 AM ET
Evaxion Biotech AS (EVAX) Competitors
The companies most similar to Evaxion Biotech AS are CEL-SCI (CVM), Edesa Biotech (EDSA) and INmune Bio (INMB). By market cap, Evaxion Biotech AS ranks 10th of the 13 companies on this page; ImageneBio (IMA) is the largest at $43.22M.
Peer Comparison
EVAX's ROIC of -79.5% is above the peer median of -102.8%, and its revenue growth of -100.0% is below the median of 0.0%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Evaxion Biotech AS (EVAX) | $25.27M | N/A | 0.2x | -115.5% | -79.5% | -100.0% | 0.00% |
| CEL-SCI Corp (CVM) | $22.51M | N/A | N/A | 0.0% | -109.0% | -62.7% | 0.00% |
| Edesa Biotech Inc (EDSA) | $26.21M | N/A | N/A | 0.0% | N/A | -99.9% | 0.00% |
| INmune Bio Inc (INMB) | $32.51M | N/A | N/A | 0.0% | N/A | 257.1% | 0.00% |
| Elicio Therapeutics Inc. (ELTX) | $42.46M | N/A | N/A | 0.0% | -96.6% | 0.0% | 0.00% |
| NextCure Inc (NXTC) | $29.31M | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| Estrella Immunopharma Inc. (ESLA) | $22.36M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Plus Therapeutics Inc (PSTV) | $26.64M | N/A | 2.0x | -230.2% | -827.8% | -2.9% | 0.00% |
| ImageneBio, Inc. (IMA) | $43.22M | N/A | 68.5x | 0.0% | N/A | 0.0% | 0.00% |
| Context Therapeutics Inc (CNTX) | $16.61M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Immutep Ltd ADR (IMMP) | $25.64M | N/A | 2.2x | 0.0% | N/A | 633.0% | 0.00% |
| Instil Bio Inc. (TIL) | $41.23M | N/A | N/A | 0.0% | -11.9% | 0.0% | 0.00% |
| Veru Inc (VERU) | $35.64M | N/A | N/A | 0.0% | N/A | 18.3% | 0.00% |
| Peer median | $27.97M | N/A | 2.2x | 0.0% | -102.8% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Evaxion Biotech AS, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| CEL-SCI Corp (CVM) | CEL-SCI Corporation is dedicated to the research and development of immunotherapy for the treatment of cancer and infectious diseases. | CVM competitors |
| Edesa Biotech Inc (EDSA) | Edesa Biotech, Inc., a clinical-stage biopharmaceutical company, is engaged in the research and development... | EDSA competitors |
| INmune Bio Inc (INMB) | INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on reprogramming the patient's innate immune system to treat cancer, Alzheimer's disease... | INMB competitors |
| Elicio Therapeutics Inc. (ELTX) | Elicio Therapeutics Inc. (ELTX) is a clinical-stage biotechnology company specializing in innovative immunotherapies for cancer treatment. | ELTX competitors |
| NextCure Inc (NXTC) | NextCure, Inc., a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of novel immunomedicines to treat cancer and other... | NXTC competitors |
| Estrella Immunopharma Inc. (ESLA) | Estrella Immunopharma, Inc., a preclinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States. | ESLA competitors |
| Plus Therapeutics Inc (PSTV) | Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacturing... | PSTV competitors |
| ImageneBio, Inc. (IMA) | ImageneBio, Inc., a clinical-stage biotechnology company, develops therapeutics for immunological and inflammatory diseases. | IMA competitors |
| Context Therapeutics Inc (CNTX) | Centrexion Therapeutics Corporation, a late-stage biopharmaceutical company, focuses on identifying, developing, and commercializing novel, non-opioid... | CNTX competitors |
| Immutep Ltd ADR (IMMP) | Immutep Limited, a biotechnology company, is dedicated to the research and development of pharmaceutical candidates. | |
| Instil Bio Inc. (TIL) | Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer patients. | TIL competitors |
| Veru Inc (VERU) | Veru Inc., an oncology biopharmaceutical company, focuses on the development of drugs for the treatment of cancers. | VERU competitors |
Frequently Asked Questions About EVAX
Who are Evaxion Biotech AS' main competitors?
The companies most similar to Evaxion Biotech AS include CEL-SCI (CVM), Edesa Biotech (EDSA), INmune Bio (INMB), Elicio Therapeutics (ELTX) and NextCure (NXTC), listed from the closest match.
Who is Evaxion Biotech AS' biggest competitor?
ImageneBio (IMA) is the largest of the similar companies at $43.22M; CEL-SCI (CVM) is the closest match by business profile, size, sector and industry.
How does EVAX stock compare with its competitors?
EVAX's P/S is 0.2x against a peer median of 2.2x; its net margin is -115.5% against a peer median of 0.0%.
Which of Evaxion Biotech AS' competitors pays a higher dividend?
Evaxion Biotech AS pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Evaxion Biotech AS bigger than its competitors?
No. Evaxion Biotech AS is 10th by market cap among the 13 companies on this page; the largest is ImageneBio (IMA) at $43.22M.
EVAX pages: Overview, Earnings, Forecast, Valuation, Competitors